Fig. 3From: Urinary angiostatin: a novel biomarker of kidney disease associated with disease severity and progressionLevels of urinary angiostatin reflect disease specificity and severity. a. Levels of urinary angiostatin in the confirmation set and validation set. Levels of urinary angiostatin/Cr in the validation set. (When compared with healthy controls and disease controls: ***P and ###P < 0.001). b. Levels of urinary angiostatin/Cr in IgAN patients with different CKD stages, Lee’s grades, mesangial proliferative and tubular atrophy, and interstitial fibrosis change scores (compared with CKD stage 1, Lee’s grade IV-V, M0, and T0, respectively; **P < 0.01 and ***P < 0.001). c. Spearman correlation analysis of urinary angiostatin/Cr levels with proteinuria levels, serum creatinine, eGFR in IgAN patientsBack to article page